RPL39 and Right ventricular hypertrophy: In particular, RPL39 knockdown significantly decreased the arterial elastance (Ea), right ventricular hypertrophy index, end-systolic pressure (Pes), end-diastolic pressure (Ped), end-systolic pressure–volume relationship (ESPVR), and end-diastolic pressure–volume relationship (EDPVR), while increasing the cardiac output (CO) and end-diastolic volume (Ved) in male-shRNA group (Figures 4(d), 4(e), 4(f), 4(g), 4(h), 4(i), 4(j), 4(k), 4(l), 4(m), 4(n), 4(o), 4(p), 4(q), 4(r), and 4(s)).